Previous 10 | Next 10 |
HippoFi accesses Precision Spine's major sales channels to speed its sales strategy & quickly drive revenue IRVINE, CA / ACCESSWIRE / October 5, 2022 / HippoFi, Inc. - formerly ORHub ® (OTC PINK:ORHB) announced today it has signed a strategic agreement with Precision Spine, In...
From the desk of CJ WIGGINS FOUNDER, EXECUTIVE CHAIRMAN & CEO of HIPPOFI,INC. IRVINE, CA / ACCESSWIRE / September 7, 2022 / I am writing to you, to share our team's accomplishments over the last 5 months and inform all parties we have changed our name to best reflect the company's c...
Born from ORHub ® , HippoFi TM represents the company's fintech focus with commitment to the ‘Hippocratic oath' and patient clinical improvements. IRVINE, CA / ACCESSWIRE / August 24, 2022 / ORHub, Inc. (OTC PINK:ORHB) announces today its future as " HippoFi" (HippoFi.com) ...
PUR Pillars TM were designed specifically for spine surgery, with a patient's post-surgical outcomes in mind. IRVINE, CA / ACCESSWIRE / July 28, 2022 / ORHub, Inc. (OTC Pink:ORHB) plans to launch its new bone growth product focused on spine surgery in early Q4 2022. Spinal fusion surg...
A proven industry leader and executive, Ryan Fernan, will help ORHub advance Ortho-Spine technology beyond current limitations. IRVINE, CA / ACCESSWIRE / July 27, 2022 / ORHub, Inc. (OTC Pink:ORHB) officially kicks off the acquisition of PUR Biologics ("PUR") with the appointment of Rya...
ORHub's new Surgical Resource Management ("SRM") platform, FutureOR, facilitates faster Case-to-Cash payments to medical device and biological vendors. IRVINE, CA / ACCESSWIRE / July 21, 2022 / ORHub, Inc. (OTC PINK:ORHB) takes form as a medical fintech company, announcing the lau...
"ORHub to launch new FutureOR TM application in Q3 2022" IRVINE, CA / ACCESSWIRE / June 9, 2022 / ORHub, Inc. (OTC PINK:ORHB) announced today it will launch its new application FutureOR TM next quarter and has expanded its relationship with Predica to support the release, provide mana...
"PUR's technologies will bring new solutions for pain elimination and osteoarthritis." IRVINE , CA / ACCESSWIRE / April 25, 2022 / ORHub, Inc. (OTC PINK:ORHB) announced today it has purchased 100% of the equity interest and assets of PUR Biologics, LLC. ORHub will enter the global med...
"ORHub plans to use PUR's patented technologies to treat osteoarthritis & joint cartilage" IRVINE, CA / ACCESSWIRE / April 15, 2022 / ORHub, Inc. (OTC Pink:ORHB) announced today it has reached a Definitive Agreement and successfully completed its due diligence of PUR Biologics, LLC....
IRVINE, CA / ACCESSWIRE / April 5, 2022 / ORHub, Inc. (OTC PINK:ORHB) ORHub announced today it has received the court ruling of an "ORDER DISMISSING WITH PREJUDICE" the litigation brought by Frederic Buonincontri and AXT Analytics, LLC in the Superior Court of the State of Arizona in and for...
News, Short Squeeze, Breakout and More Instantly...
(NewsDirect) The healthcare technology industry is one that offers investors a plethora of opportunities. With global healthcare spending soaring to approximately $8.3 trillion and nearly half of that amount allocated in the U.S. alone, the sector presents intriguing growth prospects. As the ...
(NewsDirect) In the domain of stock trading, opportunities often arise in unexpected places, including stocks priced under $0.10. Despite being often overlooked, these stocks can pack a punch in terms of potential gains, catching the eye of savvy investors. Let’s take a look at a f...
(NewsDirect) Orthobiologics represents a dynamic field within healthcare where the body's natural healing mechanisms address osteoarthritis and enhance recovery from tendon and ligament injuries. These therapies signify a significant evolution in medical treatment, offering promising solution...